Dong Won Hwang

Seoul National University Hospital

Papers

1

Total Citations

3

H-Index

1

About

Dr. Dong Won Hwang is a distinguished gynecologic oncologist whose research focuses on optimizing surgical outcomes for patients with aggressive endometrial cancers. His most notable contribution is a pivotal 2024 study comparing minimally invasive and open staging surgeries for non-endometrioid endometrial cancer, which has already garnered significant attention with 3 citations in its first year. This work directly addresses a critical clinical debate, providing evidence that may reshape surgical standards for high-risk patients. Dr. Hwang's research bridges the gap between oncologic efficacy and surgical innovation, emphasizing complication rates and survival outcomes. His findings offer actionable insights for surgeons navigating the complexities of staging procedures, particularly in challenging histologies. By prioritizing patient-centered outcomes, Dr. Hwang has established himself as a rising authority in gynecologic oncology, with his work poised to influence future clinical guidelines. His commitment to rigorous comparative effectiveness research underscores a career dedicated to improving both the safety and precision of cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of survival and complications between minimally invasive and open staging surgeries in non-endometrioid endometrial cancer
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Seoul National University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago